Abstract
Results of recent clinical trials in patients with stable angina and chronic heart failure have successfully demonstrated a beneficial role of use of ivabradine in addition to the conventional therapy. Based on the results of these trials, the aim of our review was to give an overview of the literature about the use of ivabradine in clinical settings outside its usual purpose.
Keywords:
Arrhythmias; cardiac failure; ischemic heart disease; myocardial infarction.
© 2014 John Wiley & Sons Ltd.
MeSH terms
-
Anti-Arrhythmia Agents / adverse effects
-
Anti-Arrhythmia Agents / therapeutic use*
-
Benzazepines / adverse effects
-
Benzazepines / therapeutic use*
-
Heart Diseases / diagnosis
-
Heart Diseases / drug therapy*
-
Heart Diseases / physiopathology
-
Humans
-
Ivabradine
-
Pulmonary Disease, Chronic Obstructive / diagnosis
-
Pulmonary Disease, Chronic Obstructive / drug therapy*
-
Pulmonary Disease, Chronic Obstructive / physiopathology
-
Treatment Outcome
Substances
-
Anti-Arrhythmia Agents
-
Benzazepines
-
Ivabradine